Pattern of pS2 protein expression in premalignant and malignant lesions of gastric mucosa

European Journal of Cancer Prevention

Volumn 5, Issue 3, 1996, Pages 169-179

  Machado, J C ^a   Carneiro, F ^a   Blin, N ^b   Sobrinho Simoes M ^a  

^a University of Porto   (Portugal)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Chronic atrophic gastritis; Gastric carcinoma; Gastric polyps; Immunohistochemistry; Intestinal metaplasia; Mucins; pS2; Stomach; Trefoil peptides

Indexed keywords

PROTEIN PS2;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; GASTRITIS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PRECANCER; PRIORITY JOURNAL; STOMACH CARCINOMA;

CULTURE TECHNIQUES; GASTRIC MUCOSA; GASTRITIS, ATROPHIC; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; POLYPS; PROTEINS; SENSITIVITY AND SPECIFICITY; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 0029942039     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008469-199606000-00005     Document Type: Article

References (48)

1. Alison MR, Chinery R, Poulsom R et al (1995). Experimental ulceration leads to sequential expression of spasmolytic polypeptide, intestinal trefoil factor, epidermal growth factor and transforming growth factor alpha mRNAs in rat stomach. J Pathol 175: 405-14.
2. Carneiro F, Moutinho-Ribeiro M, David L et al (1992). Signet ring cell carcinoma of the stomach: a morphometric, ultrastructural and DNA cytometric study. Ultrastruct Pathol 16: 603-14.
3. Carneiro F, David L, Seruca R et al (1993a). Hyperplastic polyposis and diffuse carcinoma of the stomach. A study of a family. Cancer 72: 323-9.
4. Carneiro F, Taveira-Gomes A, Cabral-Correia A et al (1993b). Characteristics of the gastric mucosa of direct relatives of patients with sporadic gastric carcinoma. Eur J Cancer Prev 2: 239-46.
5. Carneiro F, Santos L, David L et al (1994). T (Thomsen-Friedenreich) antigen and other simple mucin-type carbohydrate antigens in precursor lesions of gastric carcinoma. Histopathology 24: 105-13.
6. Carneiro F, Santos L, Sobrinho-Simões M (1995a). Carcinoma arising in gastric hyperplastic polyps [letter]. Gastrointest Endosc 41: 178-9.
7. Carneiro F, Seixas M, Sobrinho-Simões M (1995b). New elements for an updated classification of the carcinomas of the stomach. Pathol Res Pract 191: 571-84.
8. Correa P (1988). Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol 83: 504-9.
9. Correa P (1992). Human gastric carcinogenesis: a multistep and multifactorial process First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52: 6735-40.
10. Correa P, Haenszel W, Cuello C et al (1990a). Gastric precancerous process in a high risk population: cohort follow-up. Cancer Res 50: 4737-40.
11. Correa P, Haenszel W, Cuello C et al (1990b). Gastric precancerous process in a high risk population: cross-sectional studies. Cancer Res 50: 4731-6.
12. Filipe MI, Jass JR (1986). Intestinal metaplasia and cancer risk. In Gastric Carcinoma (eds Filipe MI, Jass JR); Churchill Livingstone, Edinburgh, pp. 87-115.
13. Filipe MI, Muqoz N, Matko I et al (1994). Intestinal metaplasia types and the risk of gastric cancer: a cohort study in Slovenia. Int J Cancer 57: 324-9.
14. Fiocca R, Villani L, Tenti P et al (1987). Characterization of four main cell types in gastric cancer: foveolar, mucopeptic, intestinal columnar and goblet cells. An histopathologic, histochemical and ultrastructural study of 'early' and 'advanced' tumors. Pathol Res Pract 182: 308-25.
15. Fiocca R, Cornaggia M, Villani L et al (1988). Expression of pepsinogen II in gastric cancer. Its relationship to local invasion and lymph node metastases. Cancer 61: 956-62.
16. Ghandur-Mnaymneh L, Paz J, Roldan E, Cassady J (1988). Dysplasia of nonmetaplastic gastric mucosa. A proposal for its classification and its possible relationship to diffuse-type gastric carcinoma. Am J Surg Pathol 12: 96-114.
17. Hanby AM, Poulsom R, Elia G et al (1993a). The expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in 'gastric metaplasia' of the proximal duodenum: implications for the nature of 'gastric metaplasia'. J Pathol 169: 355-60.
18. Hanby AM, Poulsom R, Singh S et al (1993b). Spasmolytic polypeptide is a major antral peptide: distribution of the trefoil peptides human spasmolytic polypeptide and pS2 in the stomach. Gastroenterology 105: 1110-6.
19. Hanby AM, Poulsom R, Singh S et al (1993c). Hyperplastic polyps: a cell lineage which both synthesizes and secretes trefoil-peptides and has phenotypic similarity with the ulcer-associated cell lineage. Am J Pathol 142: 663-8.
20. Hanby AM, Jankowski JA, Elia G, Poulsom R, Wright NA (1994). Expression of the trefoil peptides pS2 and human spasmolytic polypeptide (hSP) in Barrett's metaplasia and the native oesophageal epithelium: delineation of epithelial phenotype. J Pathol 173: 213-9.
21. Hattori T (1985). Morphological range of hyperplastic polyps and carcinomas arising in hyperplastic polyps of the stomach. J Clin Pathol 38: 622-30.
22. Hauser F, Hoffmann W (1992). P-domains as shuffled cysteine-rich modules in integumentary mucin C.1 (FIM-C.1) from Xenopus laevis. Polydispersity and genetic polymorphism. J Biol Chem 267: 24620-4.
23. Hauser F, Poulsom R, Chinery R et al (1993). hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus. Proc Natl Acad Sci USA 90: 6961-5.
24. Henry JA, Nicholson S, Hennessy C et al (1990). Expression of the oestrogen regulated pNR-2 mRNA in human breast cancer: relation to oestrogen receptor mRNA levels and response to tamoxifen therapy. Br J Cancer 61: 32-8.
25. Henry JA, Bennett MK, Piggott NH et al (1991). Expression of the pNR-2/pS2 protein in diverse human epithelial tumours. Br J Cancer 64: 677-82.
26. Hsu SM, Raine L, Fanger H (1981). A comparative study of the peroxidase antiperoxidase method and an avidin biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies. Am J Clin Pathol 75: 734-8.
27. Kushima R, Hattori T (1993). Histogenesis and characteristics of gastric-type adenocarcinomas in the stomach. J Cancer Res Clin Oncol 120: 103-11.
28. Laurén P (1965). The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Pathol Microbiol Scand 64: 31-49.
29. Luqmani Y, Bennett C, Paterson I et al (1989). Expression of the pS2 gene in normal, benign and neoplastic human stomach. Int J Cancer 44: 806-12.
30. Machado JC, Carneiro F, Gärtner F, Ribeiro P, Sobrinho-Simões M (1994). Female sex hormone receptors are not involved in gastric carcinogenesis. A biochemical and immunohistochemical study. Eur J Cancer Prev 3 (Suppl 2): 31-7.
31. Masiakowski P, Breathnach R, Bloch J et al (1982). Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res 10: 7895-903.
32. Müller W, Borchard F (1993). pS2 protein in gastric carcinoma and normal gastric mucosa: association with clinicopathological parameters and patient survival. J Pathol 171: 263-9.
33. Piggott NH, Henry JA, May FE, Westley BR (1991). Antipeptide antibodies against the pNR-2 oestrogen-regulated protein of human breast cancer cells and detection of pNR-2 expression in normal tissues by immunohistochemistry. J Pathol 163: 95-104.
34. Podolsky DK, Lynch-Devancy K, Stow JL et al (1993). Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 268: 6694-702.
35. Rio MC, Bellocq JP, Gairard B et al (1987). Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. Proc Natl Acad Sci USA 84: 9243-7.
36. Rio MC, Bellocq JP, Daniel JY et al (1988). Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science 241: 705-8.
37. Rio MC, Chenard MP, Wolf C et al (1991). Induction of pS2 and hSP genes as markers of mucosal ulceration of the digestive tract. Gastroenterology 100: 375-9.
38. Seitz G, Theisinger B, Tomasetto C et al (1991). Breast cancer-associated protein pS2 expression in tumors of the biliary tract. Am J Gastroenterol 86: 1491-4.
39. Sipponen P, Seppala K, Varis K et al (1980). Intestinal metaplasia with colonic-type sulphomucins in the gastric mucosa its association with gastric carcinoma. Acta Pathol Microbiol Scand A 88: 217-24.
40. Theisinger B, Welter C, Seitz G et al (1991). Expression of the breast cancer associated gene pS2 and the pancreatic spasmolytic polypeptide gene (hSP) in diffuse type of stomach carcinoma. Eur J Cancer 27: 770-3.
41. Thim L (1994). Trefoil peptides: a new family of gastrointestinal molecules. Digestion 55: 353-60.
42. Thim L, Thomsen J, Christensen M, Jorgensen KH (1985). The amino acid sequence of pancreatic spasmolytic polypeptide. Biochim Biophys Acta 827: 410-8.
43. Watanabe H, Kato N, Fuchigami T et al (1992). Natural history of gastric carcinoma from analysis of microcarcinoma. Stomach Intestine 27: 59-67.
44. Welter C, Theisinger B, Rio MC et al (1994). Expression pattern of breast-cancer-associated protein pS2/BCEI in colorectal tumors. Int J Cancer 56: 52-5.
45. Whitehead R (1985). Gastritis. In Mucosal Biopsy of the Gastrointestinal Tract (ed Whitehead R); W B Saunders Company, Philadelphia, pp. 41-58.
46. Wright NA, Poulsom R, Stamp GW et al (1990). Epidermal growth factor (EGF/URO) induces expression of regulatory peptides in damaged human gastrointestinal tissues. J Pathol 162: 279-84.
47. Wright NA, Poulsom R, Stamp G et al (1993). Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 104: 12-20.
48. Zea-Iriarte WL, Itsuno M, Makiyama K et al (1995). Signet ring cell carcinoma in hyperplastic polyp. Scand J Gastroenterol 30: 604-8.